• LAST PRICE
    0.0838
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.0650/ 100
  • Ask / Lots
    0.1000/ 67
  • Open / Previous Close
    0.0000 / 0.0838
  • Day Range
    ---
  • 52 Week Range
    Low 0.0520
    High 0.2900
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesABTI
Alterola Biotech Inc
67.6M
-9.1x
---
United StatesAPTO
Aptose Biosciences Inc
66.9M
-1.2x
---
United StatesPRDS
Pardes Biosciences Inc
69.2M
-0.8x
---
United StatesELYM
Eliem Therapeutics Inc
65.9M
-1.4x
---
United StatesLBPH
Longboard Pharmaceuticals Inc
70.6M
-1.7x
---
United StatesIMPL
Impel Pharmaceuticals Inc
68.1M
-0.6x
---
As of 2022-12-08

Company Information

Alterola Biotech, Inc. is a pharmaceutical company. The Company is developing cannabinoid, cannabinoid-like, and non-cannabinoid pharmaceutical active pharmaceutical ingredients (APIs). The Company has three areas of focus: development of regulated pharmaceuticals (human and animal health) and regulated food products; production of APIs and food-grade ingredients; and formulation, and drug delivery, providing bioavailability, solubility, and stability. It also focuses on developing new medicines from various sources, including botanical, traditional chemical synthesis, and biosynthetic methodologies. Its subsidiaries include ABTI Pharma Limited, Phytotherapeutix Ltd, and Ferven Ltd.

Contact Information

Headquarters
47 Hamilton SquarBIRKENHEAD, CA, United Kingdom CH415AR
Phone
909-584-5853
Fax
---

Executives

Chairman of the Board, Chief Financial Officer
Timothy Rogers
Chief Executive Officer, Director
David Hitchcock
Chief Operating Officer, Director
Colin Stott
Vice President - Translational Research, Executive Director
Hunter Land
Executive Director
Daniel Reshef

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$67.6M
Revenue (TTM)
$0.00
Shares Outstanding
807.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
-3.45
EPS
$-0.01
Book Value
$0.01
P/E Ratio
-9.1x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.